CXCR4 and non-small cell lung carcinoma: In addition, NSCLC patients with CXCR4 expression were more likely to be diagnosed with adenocarcinoma cancer (OR = 1.45, 95% CI = 1.07–1.95, p = 0.016), lymph node involvement (OR = 0.69, 95% CI = 0.50–0.96, p = 0.027), and distant metastasis (OR = 0.36, 95% CI = 0.14–0.93, p = 0.035).